Navigation Links
Research about Brazilian marine biodiversity brings researchers from 5 countries together
Date:9/3/2010

The So Paulo Research Foundation (FAPESP) presents the Marine Biodiversity Workshop: Recent Improvements in Bioprospection, Biogeography and Phylogeography to be held on September 9 and 10. This scientific meeting is intended to stimulate the formation of research groups involving both Brazilian and foreign scientists towards the development of research on bioprospection, geographic distribution of sea organisms in the Brazilian Coast as well as the search for natural bioactive compounds for pharmaceutical production.

The Marine Biodiversity Workshop also proposes research incentives for the production of data to support the making of laws about the use and protection of diverse marine biomes such as the ones that have already been created in the State of So Paulo with data produced since 1999 by the Biota-FAPESP Program for terrestrial biomes.

"It is a Biota-FAPESP Program's desire to stimulate research and enhance the debate on the sustainable use of Brazilian marine biodiversity resources in cooperative projects involving research groups from Brazil and other countries", says Roberto Berlinck, professor of the Chemistry Institute of the University of So Paulo (USP). "Thus, it will be also possible to educate more scientists to act in this area", concludes the researcher, who takes part of the workshop organization.

Participants from Brazil, the USA, New Zealand, Canada, and Belgium are going to discuss the obtainment of products through different biotechnological applications, the planning of human intervention in the sea environment when faced with the economic relevance of activities such as low environmental impact fishing and the Brazilian marine biodiversity characterization itself.

William Fenical, from the Center for Marine Biotechnology and Biomedicine (CMBB) of University of California, San Diego (UCSD), researches organic compounds derived from marine microorganisms with effect on cancer and other diseases. In a recent research, he discovered the bacteria known as Salinospora tropica in sediments of the Atlantic Ocean, in a region close to the Bahamas. These bacteria produce an anticarcinogenic agent with a high potential to treat multiple myeloma. The next step is performing tests in human beings. He also discovered a new anti-inflammatory drug derived from soft coral, pseudopterosine, which has already been employed in facial moisturizers produced by the cosmetic industry.

Other compounds with a potential for the development of anticancer drugs found in ocean invertebrates are investigated by Raymond Andersen, from the British Columbia University, in Vancouver (Canada).

Letcia Veras Costa-Lotufo, Department of Physiology and Pharmacology, University of Cear, is going to present results from research for the discovery of compounds to treat cancer. These compounds were obtained in invertebrates and microorganisms collected from the Northeastern Coast of Brazil and have reached the pre-clinical stage. Paulo Mouro, Medical Biochemistry Institute, Federal University of Rio de Janeiro, is going to present results from research on anticoagulant and antithrombotic agents found in sea urchins.

The expansion of multidisciplinary research on marine biodiversity takes part of a strategy defined in 2009 for the forthcoming 10 years of the Biota-FAPESP Program, which has been supporting research on biodiversity for over 10 years now. A few themes proposed for research projects about marine biodiversity are: the making of inventories about seaside organisms; identification of environmental factors that affect their distribution and abundance; studies about the interactions of such organisms as well as about the environmental impact caused by oil and gas exploitation; and the production of data about biodiversity that might be incorporated to the Brazilian climatic change models.


'/>"/>

Contact: Fernando Cunha
cunha@fapesp.br
55-113-838-4151
Fundao de Amparo Pesquisa do Estado de So Paulo
Source:Eurekalert

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. NC State researchers get to root of parasite genome
3. White Mountain Research Station to host climate change conference
4. Stevens awarded $1M for advanced biofuels research
5. Researchers find animal with ability to survive climate change
6. Researchers find an essential gene for forming ears of corn
7. Researchers note differences between people and animals on calorie restriction
8. Researcher working on destruction of chemical weapons
9. Researchers study acoustic communication in deep-sea fish
10. Researchers discover that growing up too fast may mean dying young in honey bees
11. The Rett Syndrome Research Trust launches operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):
(Date:3/1/2017)... WA (PRWEB) , ... March 01, 2017 , ... ... research into the physiology of aging into clinical applications, announces the formation of ... proprietary oral-transmucosal dosage form of resveratrol, the drug which has been discussed in ...
(Date:2/28/2017)... Linda, Ca (PRWEB) , ... February 28, 2017 , ... ... molecular interactions. SPR is an optical phenomenon that is sensitive to changes in the ... resonance condition is affected by changes in refractive index occurring up to 300 nm ...
(Date:2/28/2017)... , Feb. 28, 2017  Phosphorus, a ... today the formation of the Phosphorus Scientific Advisory ... experts chosen to advise the company on the ... multi-site research initiatives. Please visit http://phosphorus.com/about-us/ ... initiatives. "We,ve gathered some of the ...
(Date:2/28/2017)... -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing ... diseases, asthma and allergic diseases and cancer, today ... full year ended December 31, 2016 and provided ... clinical highlights. "During 2016, we made ... starting five clinical trials across our XmAb portfolio.  ...
Breaking Biology Technology: